Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human serum paraoxonase

B Mackness1, P N Durrington, M I Mackness

  • 1University Department of Medicine, Manchester Royal Infirmary, United Kingdom. bmack@central.cmht.nwest.nhs.uk

General Pharmacology
|August 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Atherosclerosis·2025
Same author

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.

Atherosclerosis·2018
Same author

The antioxidant properties of high-density lipoproteins in atherosclerosis.

Panminerva medica·2012
Same author

The role of combined assessment of defense against oxidative stress and inflammation in the evaluation of peripheral arterial disease.

Current molecular medicine·2011
Same author

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology·2011
Same author

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

Diabetic medicine : a journal of the British Diabetic Association·2010
Same journal

Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces endothelin-dependent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Reversal of hypercapnia induces KATP channel and NO-independent constriction of basilar artery in rabbits with acute metabolic alkalosis.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. II. Effect of cholestyramine on enhanced contractile response of aorta to norepinephrine in C57BL/KsJ (db/db) mice.

General pharmacology·2002
Same journal

Contractile responses in spontaneously diabetic mice. I. Involvement of superoxide anion in enhanced contractile response of aorta to norepinephrine in C57BL/KsJ(db/db) mice.

General pharmacology·2002
Same journal

Investigation of basal endothelial function in the obese Zucker rat in vitro.

General pharmacology·2002
See all related articles

Human serum paraoxonase (PON1) genetic variations influence organophosphate (OP) susceptibility and cardiovascular disease risk. Identifying PON1 polymorphisms aids in predicting OP poisoning risk and understanding Gulf War syndrome, as well as coronary heart disease development.

Area of Science:

  • Biochemistry
  • Genetics
  • Toxicology

Background:

  • Human serum paraoxonase (PON1) is a calcium-dependent glycoprotein linked to high-density lipoprotein (HDL).
  • PON1 plays a crucial role in hydrolyzing organophosphate (OP) insecticides and nerve agents, influencing mammalian toxicity.
  • Genetic variations in PON1, specifically at positions 55 and 192, significantly affect its activity and substrate hydrolysis.

Purpose of the Study:

  • To investigate the impact of PON1 genetic polymorphisms on OP detoxification and atherosclerosis protection.
  • To explore the potential of PON1 genotyping for identifying individuals at higher risk of OP poisoning.
  • To elucidate the role of PON1 polymorphisms in Gulf War syndrome and coronary heart disease (CHD) development.

Main Methods:

Related Experiment Videos

  • Analysis of human serum paraoxonase (PON1) enzyme activity.
  • Genotyping of individuals for PON1 polymorphisms at positions 55 and 192.
  • In vitro studies assessing HDL's capacity to protect low-density lipoprotein (LDL) against oxidative modification.

    • Main Results:

    • The position-192 polymorphism is a primary determinant of PON1 activity, with the position-55 polymorphism also modulating enzyme function.
    • PON1 polymorphisms influence susceptibility to OP poisoning and may explain differential Gulf War syndrome development among veterans.
    • PON1 activity, influenced by its genetic variants, affects HDL's ability to prevent LDL oxidation, linking PON1 alleles to CHD risk.

    Conclusions:

    • PON1 genetic polymorphisms are critical determinants of OP detoxification capacity and cardiovascular disease risk.
    • Genotyping for PON1 variants offers a potential tool for personalized risk assessment of OP exposure and related health outcomes.
    • Understanding PON1's role in lipoprotein protection sheds light on its association with atherosclerosis and coronary heart disease.